| News
January 2012
Cellophil™ thermo- responsive drug delivery systems used in ophthalmology
and dermatology »
Board of Directors announces appointment of Christoph Schäfer as Chief
Executive Officer »
Ophthalmic super-generics in preservative-free multidose delivery systems
»
Cellophil™ drug-eluting stents »
Biomimetic skin treatment »
|